Cargando…

Low frequency novel interictal EEG biomarker for localizing seizures and predicting outcomes

Localizing hyperexcitable brain tissue to treat focal seizures remains challenging. We want to identify the seizure onset zone from interictal EEG biomarkers. We hypothesize that a combination of interictal EEG biomarkers, including a novel low frequency marker, can predict mesial temporal involveme...

Descripción completa

Detalles Bibliográficos
Autores principales: Lundstrom, Brian Nils, Brinkmann, Benjamin H, Worrell, Gregory A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8536865/
https://www.ncbi.nlm.nih.gov/pubmed/34704030
http://dx.doi.org/10.1093/braincomms/fcab231
_version_ 1784588109046874112
author Lundstrom, Brian Nils
Brinkmann, Benjamin H
Worrell, Gregory A
author_facet Lundstrom, Brian Nils
Brinkmann, Benjamin H
Worrell, Gregory A
author_sort Lundstrom, Brian Nils
collection PubMed
description Localizing hyperexcitable brain tissue to treat focal seizures remains challenging. We want to identify the seizure onset zone from interictal EEG biomarkers. We hypothesize that a combination of interictal EEG biomarkers, including a novel low frequency marker, can predict mesial temporal involvement and can assist in prognosis related to surgical resections. Interictal direct current wide bandwidth invasive EEG recordings from 83 patients implanted with 5111 electrodes were retrospectively studied. Logistic regression was used to classify electrodes and patient outcomes. A feed-forward neural network was implemented to understand putative mechanisms. Interictal infraslow frequency EEG activity was decreased for seizure onset zone electrodes while faster frequencies such as delta (2–4 Hz) and beta-gamma (20–50 Hz) activity were increased. These spectral changes comprised a novel interictal EEG biomarker that was significantly increased for mesial temporal seizure onset zone electrodes compared to non-seizure onset zone electrodes. Interictal EEG biomarkers correctly classified mesial temporal seizure onset zone electrodes with a specificity of 87% and positive predictive value of 80%. These interictal EEG biomarkers also correctly classified patient outcomes after surgical resection with a specificity of 91% and positive predictive value of 87%. Interictal infraslow EEG activity is decreased near the seizure onset zone while higher frequency power is increased, which may suggest distinct underlying physiologic mechanisms. Narrowband interictal EEG power bands provide information about the seizure onset zone and can help predict mesial temporal involvement in seizure onset. Narrowband interictal EEG power bands may be less useful for predictions related to non-mesial temporal electrodes. Together with interictal epileptiform discharges and high-frequency oscillations, these interictal biomarkers may provide prognostic information prior to surgical resection. Computational modelling suggests changes in neural adaptation may be related to the observed low frequency power changes.
format Online
Article
Text
id pubmed-8536865
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-85368652021-10-25 Low frequency novel interictal EEG biomarker for localizing seizures and predicting outcomes Lundstrom, Brian Nils Brinkmann, Benjamin H Worrell, Gregory A Brain Commun Original Article Localizing hyperexcitable brain tissue to treat focal seizures remains challenging. We want to identify the seizure onset zone from interictal EEG biomarkers. We hypothesize that a combination of interictal EEG biomarkers, including a novel low frequency marker, can predict mesial temporal involvement and can assist in prognosis related to surgical resections. Interictal direct current wide bandwidth invasive EEG recordings from 83 patients implanted with 5111 electrodes were retrospectively studied. Logistic regression was used to classify electrodes and patient outcomes. A feed-forward neural network was implemented to understand putative mechanisms. Interictal infraslow frequency EEG activity was decreased for seizure onset zone electrodes while faster frequencies such as delta (2–4 Hz) and beta-gamma (20–50 Hz) activity were increased. These spectral changes comprised a novel interictal EEG biomarker that was significantly increased for mesial temporal seizure onset zone electrodes compared to non-seizure onset zone electrodes. Interictal EEG biomarkers correctly classified mesial temporal seizure onset zone electrodes with a specificity of 87% and positive predictive value of 80%. These interictal EEG biomarkers also correctly classified patient outcomes after surgical resection with a specificity of 91% and positive predictive value of 87%. Interictal infraslow EEG activity is decreased near the seizure onset zone while higher frequency power is increased, which may suggest distinct underlying physiologic mechanisms. Narrowband interictal EEG power bands provide information about the seizure onset zone and can help predict mesial temporal involvement in seizure onset. Narrowband interictal EEG power bands may be less useful for predictions related to non-mesial temporal electrodes. Together with interictal epileptiform discharges and high-frequency oscillations, these interictal biomarkers may provide prognostic information prior to surgical resection. Computational modelling suggests changes in neural adaptation may be related to the observed low frequency power changes. Oxford University Press 2021-10-06 /pmc/articles/PMC8536865/ /pubmed/34704030 http://dx.doi.org/10.1093/braincomms/fcab231 Text en © The Author(s) (2021). Published by Oxford University Press on behalf of the Guarantors of Brain. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Original Article
Lundstrom, Brian Nils
Brinkmann, Benjamin H
Worrell, Gregory A
Low frequency novel interictal EEG biomarker for localizing seizures and predicting outcomes
title Low frequency novel interictal EEG biomarker for localizing seizures and predicting outcomes
title_full Low frequency novel interictal EEG biomarker for localizing seizures and predicting outcomes
title_fullStr Low frequency novel interictal EEG biomarker for localizing seizures and predicting outcomes
title_full_unstemmed Low frequency novel interictal EEG biomarker for localizing seizures and predicting outcomes
title_short Low frequency novel interictal EEG biomarker for localizing seizures and predicting outcomes
title_sort low frequency novel interictal eeg biomarker for localizing seizures and predicting outcomes
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8536865/
https://www.ncbi.nlm.nih.gov/pubmed/34704030
http://dx.doi.org/10.1093/braincomms/fcab231
work_keys_str_mv AT lundstrombriannils lowfrequencynovelinterictaleegbiomarkerforlocalizingseizuresandpredictingoutcomes
AT brinkmannbenjaminh lowfrequencynovelinterictaleegbiomarkerforlocalizingseizuresandpredictingoutcomes
AT worrellgregorya lowfrequencynovelinterictaleegbiomarkerforlocalizingseizuresandpredictingoutcomes